Novel theranostic strategies in oncology precision management

In recent years, traditional cancer treatments, such as surgery, chemotherapy, and radiation treatment, etc., may damage the pathological tissue and normal cells. However, the current oncology precision management should be noninvasive, precise target tumor, making the body produce systemic tumor-specific immunity, eliminating metastases, and having less /no side effects. With the development of immunotherapy and various 3D technology, scientists have promoted precise tumor therapy from the application of targeted therapy, and immunotherapy, which have good efficacy and less adverse effect. Recent therapeutic strategies such as nano-immunotherapy, immunotherapy, and so on. Novel theranostic strategies in oncology precision management not only have the advantages of traditional therapy but also have the precision targeting ability of cancer. So, this special issue will collect novel theranostic strategies in advance to provide the latest treatment for scientists. It will focus on research concerning novel strategies in oncology precision management: from bench to translational research.

14/09/2024